Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Viatris Promises Clarity And Certainty On $9bn Transformation Plans
As Company Sticks With 2022 FY Guidance Following Q1 Financials
May 10 2022
•
By
Dean Rudge
Viatris says it is aware of concerns over clarity • Source: Shutterstock
More from Earnings
More from Business